Insider trades by month
US insider trades, June 2023
The 11,204 open-market buys and sales by US company CEOs, executives and directors filed in June 2023.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
White Mountains Insurance GroupDirector | MediaAlphaMAX | Open-market buy | 23/06/30 | 23/06/30 | 5,916,816 sh | $10.00 | $59,168,160 | +34.9% |
Credo Technology Group HoldingCRDO | Open-market sale | 23/06/23–23/06/30 | 23/06/30 | 243,596 sh6 trades | $17.71avg. | $4,314,764.6 | −5.8% | |
Copper Property CTL Pass Through TrustCPPTL | Open-market sale | 23/06/28–23/06/30 | 23/06/30 | 140,000 sh2 trades | $10.38avg. | $1,453,200 | −1.5% | |
Matthew J. CoxChairman & CEO | MatsonMATX | Open-market sale | 23/06/30 | 23/06/30 | 10,000 sh | $77.43 | $774,300 | −4.0% |
Gray MediaGTN | Open-market buy | 23/06/29–23/06/30 | 23/06/30 | 2,000 sh2 trades | $9.51avg. | $19,010 | +0.1% | |
CSI Compressco | Open-market buy | 23/06/30 | 23/06/30 | 25,000 sh | $1.30 | $32,500 | +3.0% | |
Steve DubinDirector | Adicet BioACET | Open-market buy | 23/06/30 | 23/06/30 | 5,000 sh | $2.40 | $12,000 | +84.7% |
Copper Property CTL Pass Through TrustCPPTL | Open-market sale | 23/06/28–23/06/30 | 23/06/30 | 140,000 sh2 trades | $10.38avg. | $1,453,200 | −1.5% | |
Paul T. QuinlanGeneral Counsel | CymaBay Therapeutics | Open-market sale | 23/06/30 | 23/06/30 | 5,000 sh | $10.05 | $50,250 | −100.0% |
Superior Industries International | Open-market sale10b5-1 plan | 23/06/28–23/06/30 | 23/06/30 | 27,331 sh3 trades | $3.55avg. | $97,120.93 | −11.0% | |
Copper Property CTL Pass Through TrustCPPTL | Open-market sale | 23/06/28–23/06/30 | 23/06/30 | 140,000 sh2 trades | $10.38avg. | $1,453,200 | −1.5% | |
Jacqualyn A. FouseDirector | Agios PharmaceuticalsAGIO | Open-market sale10b5-1 plan | 23/06/30 | 23/06/30 | 10,718 sh | $28.36 | $303,962.48 | −9.1% |
Scott B. UllemCVP, CFO | Edwards LifesciencesEW | Open-market sale10b5-1 plan | 23/06/30 | 23/06/30 | 7,255 sh | $93.27 | $676,673.85 | −27.4% |
Fennec PharmaceuticalsFENC | Open-market sale10b5-1 plan | 23/06/28–23/06/30 | 23/06/30 | 25,000 sh3 trades | $8.93avg. | $223,325 | −16.7% | |
Barry L. PadgettDirector | FreshworksFRSH | Open-market sale10b5-1 plan | 23/06/30 | 23/06/30 | 6,559 sh | $17.58 | $115,307.22 | −28.5% |
Goff BrianCEO | Agios PharmaceuticalsAGIO | Open-market sale10b5-1 plan | 23/06/30 | 23/06/30 | 11,449 sh | $28.36 | $324,693.64 | −44.8% |
Gray MediaGTN | Open-market buy | 23/06/29–23/06/30 | 23/06/30 | 2,000 sh2 trades | $9.51avg. | $19,010 | +0.1% | |
Avid Bioservices | Open-market sale | 23/06/29–23/06/30 | 23/06/30 | 3,657 sh2 trades | $12.98avg. | $47,455.1 | −7.2% | |
Tilly'sTLYS | Open-market buy | 23/06/28–23/06/30 | 23/06/30 | 20,000 sh2 trades | $6.96avg. | $139,200 | +0.5% | |
Tilly'sTLYS | Open-market buy | 23/06/28–23/06/30 | 23/06/30 | 20,000 sh2 trades | $6.96avg. | $139,200 | +0.5% |
Other months
- September 20262,606
- June 202620,298
- May 202614,504
- April 20269,432
- March 202614,721
- February 202610,638
- January 20267,844
- December 202512,093
- November 202511,751
- October 202513,072
- September 202513,090
- August 202514,381
- July 20258,748
- June 202511,426
- May 202511,415
- April 20256,792
- March 202512,399
- February 202510,686
- January 20258,151
- December 202416,069
- November 202416,983
- October 20248,518
- September 202410,511
- August 202414,013
- July 202410,847
- June 202412,704
- May 202412,649
- April 20248,608
- March 202417,622
- February 202413,916
- January 20249,748
- December 202314,239
- November 202312,685
- October 20236,365
- September 20239,845
- August 202312,892
- July 20237,232
- June 202311,204
- May 202313,009
- April 20235,870
- March 202313,084
- February 202311,300
- January 20238,626